Found: 53
Select item for more details and to access through your institution.
Advances in chemotherapy.
- Published in:
- Patient Care (Print), 1998, v. 32, n. 4, p. 42
- By:
- Publication type:
- Article
Synergistic antiproliferative effects of glucocorticoids and interferon-α on some lymphoid cell lines.
- Published in:
- Journal of Cellular Physiology, 1988, v. 134, n. 1, p. 85, doi. 10.1002/jcp.1041340110
- By:
- Publication type:
- Article
Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 12, p. 929
- By:
- Publication type:
- Article
Increased Circulating Nitrogen Oxides After Human Tumor Immunotherapy: Correlation With Toxic Hemodynamic Changes.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 11, p. 864
- By:
- Publication type:
- Article
Kinetics of Recovery of CD4 T Cells in Peripheral Blood of Deoxycoformycin-Treated Patients.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 22, p. 1678
- By:
- Publication type:
- Article
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Advanced Malignancy: A Phase Ib Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 8, p. 697
- By:
- Publication type:
- Article
Phorbol Ester-Induced, Cell-Cycle-Specific, Growth Inhibition of Human B-Lymphoma Cell Lines.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 6, p. 501
- By:
- Publication type:
- Article
Low-Versus High-Dose Interferon Alfa-2a in Relapsed Indolent Non-Hodgkin's Lymphoma1.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 3, p. 235, doi. 10.1093/jnci/82.3.235
- By:
- Publication type:
- Article
Use of Prophylactic Antibiotics for Prevention of Intravascular Catheter-Related Infections in Interleukin-2-Treated Patients12.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 15, p. 1190
- By:
- Publication type:
- Article
BOOK REVIEWS.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 13, p. 1039, doi. 10.1093/jnci/81.13.1039
- By:
- Publication type:
- Article
Intraperitoneal Lymphokine-Activated Killer Cell/Interleukin-2 Therapy in Patients With Intra- abdominal Cancer: Immunologic Considerations.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 8, p. 602
- By:
- Publication type:
- Article
Immunomodulation of Natural Killer Cell Activity by Flavone Acetic Acid: Occurrence Via Induction of Interferon α/β2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 15, p. 1226
- By:
- Publication type:
- Article
Enhancement of Natural Killer Activity in Human Peripheral Blood by Flavone Acetic Acid23.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 7, p. 521
- By:
- Publication type:
- Article
Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study.
- Published in:
- Clinical Genitourinary Cancer, 2009, v. 7, n. 3, p. E58, doi. 10.3816/CGC.2009.n.025
- By:
- Publication type:
- Article
Levamisole-Induced Neopterin Synthesis.
- Published in:
- Annals of the New York Academy of Sciences, 1993, v. 685, n. 1, p. 252, doi. 10.1111/j.1749-6632.1993.tb35873.x
- By:
- Publication type:
- Article
Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules.
- Published in:
- International Journal of Cancer, 1998, v. 78, n. 1, p. 16, doi. 10.1002/(SICI)1097-0215(19980925)78:1<16::AID-IJC4>3.0.CO;2-#
- By:
- Publication type:
- Article
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.
- Published in:
- Annals of the New York Academy of Sciences, 2013, v. 1291, n. 1, p. 1, doi. 10.1111/nyas.12180
- By:
- Publication type:
- Article
Regression of bone metastases following adoptive transfer of anti-CD3-activated and IL-2-expanded tumor vaccine draining lymph node cells.
- Published in:
- Clinical & Experimental Metastasis, 2004, v. 21, n. 4, p. 305, doi. 10.1023/B:CLIN.0000046139.59515.4e
- By:
- Publication type:
- Article
Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression.
- Published in:
- Scientific Reports, 2016, p. 37558, doi. 10.1038/srep37558
- By:
- Publication type:
- Article
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Immunotherapy for melanoma: The good, the bad, and the future.
- Published in:
- Current Oncology Reports, 2005, v. 7, n. 5, p. 383, doi. 10.1007/s11912-005-0066-1
- By:
- Publication type:
- Article
GMP-grade α-TEA lysine salt: a 28-Day oral toxicity and toxicokinetic study with a 28-Day recovery period in Beagle dogs.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Emerging Antibody-Based Therapy for Patients With Advanced Melanoma.
- Published in:
- Oncology (08909091), 2008, v. 22, p. 25
- By:
- Publication type:
- Article
Primary tracheal non-Hodgkin's lymphoma: A case report and review of the literature.
- Published in:
- Cancer (0008543X), 1996, v. 77, n. 11, p. 2332, doi. 10.1002/(SICI)1097-0142(19960601)77:11<2332::AID-CNCR23>3.0.CO;2-X
- By:
- Publication type:
- Article
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Science gone translational: the OX40 agonist story.
- Published in:
- Immunological Reviews, 2011, v. 244, n. 1, p. 218, doi. 10.1111/j.1600-065X.2011.01069.x
- By:
- Publication type:
- Article
SARS-CoV-2 Antibodies Detected in Mother's Milk Post-Vaccination.
- Published in:
- Journal of Human Lactation, 2021, v. 37, n. 3, p. 492, doi. 10.1177/08903344211030168
- By:
- Publication type:
- Article
Integrating New Therapies in the Treatment of Advanced Melanoma.
- Published in:
- Current Treatment Options in Oncology, 2012, v. 13, n. 3, p. 327, doi. 10.1007/s11864-012-0201-9
- By:
- Publication type:
- Article
Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Targeting and amplification of immune killing of tumor cells by pro-Smac.
- Published in:
- International Journal of Cancer, 2004, v. 109, n. 1, p. 85, doi. 10.1002/ijc.11655
- By:
- Publication type:
- Article
Spontaneous mammary carcinomas fail to induce an immune response in syngeneic FVBN202 neu transgenic mice.
- Published in:
- International Journal of Cancer, 2000, v. 87, n. 5, p. 688, doi. 10.1002/1097-0215(20000901)87:5<688::AID-IJC11>3.0.CO;2-E
- By:
- Publication type:
- Article
Mutated cytochrome b as a determinant of a new monoclonal antibody (H8.98) on renal carcinoma cell lines recognized by a Vγ3Vδ1.
- Published in:
- International Journal of Cancer, 1999, v. 82, n. 4, p. 562, doi. 10.1002/(SICI)1097-0215(19990812)82:4<562::AID-IJC15>3.0.CO;2-W
- By:
- Publication type:
- Article
Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studies.
- Published in:
- Immunology, 2003, v. 108, n. 3, p. 409, doi. 10.1046/j.1365-2567.2003.01596.x
- By:
- Publication type:
- Article
Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2: Tumor and Immunological Responses.
- Published in:
- Science Translational Medicine, 2012, v. 4, n. 137, p. 1, doi. 10.1126/scitranslmed.3003649
- By:
- Publication type:
- Article
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-100
- By:
- Publication type:
- Article
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment.
- Published in:
- Journal of Translational Medicine, 2012, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-54
- By:
- Publication type:
- Article
The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program.
- Published in:
- 2011
- By:
- Publication type:
- journal article
The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program.
- Published in:
- Journal of Translational Medicine, 2011, v. 9, n. 1, p. 18, doi. 10.1186/1479-5876-9-18
- By:
- Publication type:
- Article
Combined IL-21 and Low-Dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model.
- Published in:
- Journal of Translational Medicine, 2006, v. 4, p. 24, doi. 10.1186/1479-5876-4-24
- By:
- Publication type:
- Article
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 510, doi. 10.1002/ajh.25757
- By:
- Publication type:
- Article
A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy.
- Published in:
- Cancer Informatics, 2022, v. 21, p. 1, doi. 10.1177/11769351221136081
- By:
- Publication type:
- Article
An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 17, p. 4098, doi. 10.1002/cncr.26730
- By:
- Publication type:
- Article
Melanoma: More Answers, More Questions.
- Published in:
- Oncologist, 2013, v. 18, n. 6, p. 658, doi. 10.1634/theoncologist.2013-0212
- By:
- Publication type:
- Article
The Effect of Superparamagnetic Iron Oxide Nanoparticle Surface Charge on Antigen Cross-Presentation.
- Published in:
- Nanoscale Research Letters, 2017, v. 12, n. 1, p. 1, doi. 10.1186/s11671-017-1828-z
- By:
- Publication type:
- Article
CD122.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 5, p. 1375, doi. 10.1002/eji.200839210
- By:
- Publication type:
- Article
Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution.
- Published in:
- European Journal of Immunology, 2003, v. 33, n. 8, p. 2123, doi. 10.1002/eji.200324034
- By:
- Publication type:
- Article